Aveanna director sells 180K shares in offering

Aveanna Healthcare Holdings, Inc. (AVAH) director Rodney D. Windley reported selling 180,000 shares of common stock on August 20, 2026 at $11.50 per share.

Rhea-AI Filing Summary

Aveanna Healthcare Holdings, Inc. (AVAH) director Rodney D. Windley reported selling 180,000 shares of common stock on August 20, 2026 at $11.50 per share. The sale was part of a 15,000,000‑share secondary offering of Aveanna common stock that closed on August 24, 2026, and left him holding 2,078,017 shares directly.

Insider Trade Summary

Net Seller: 180,000 shares

Net Sell 1 txn

Insider Windley Rodney D

Role Director

Sold 180,000 shs ($2.07M)

Type	Security	Shares	Price	Value
Sale	Common Stock, par value $0.01 per share F1	180,000	$11.50	$2.07M

Holdings After Transaction: Common Stock, par value $0.01 per share — 2,078,017 shares (Direct)

Footnotes (1)

1. F1. Shares sold by the reporting person were part of an undewritten secondary offering of 15,000,000 shares of the Issuer's common stock which closed on August 24, 2026.

Key Figures

Shares sold: 180,000 shares Sale price per share: $11.50 per share Shares held after transaction: 2,078,017 shares +1 more

4 metrics

Shares sold 180,000 shares Sale of Aveanna common stock by director Rodney D. Windley on August 20, 2026

Sale price per share $11.50 per share Price for the 180,000 Aveanna common shares sold on August 20, 2026

Shares held after transaction 2,078,017 shares Direct holdings of Aveanna common stock by Rodney D. Windley following the sale

Secondary offering size 15,000,000 shares Secondary offering of Aveanna common stock that included the insider’s sale and closed August 24, 2026

Key Terms

secondary offering, non-derivative, beneficially holds

3 terms

secondary offering financial

"part of an undewritten secondary offering of 15,000,000 shares of the Issuer's common"

A secondary offering is when a company sells new shares of its stock to the public after its initial sale. This allows existing shareholders or the company itself to raise additional money. For investors, it can impact the stock’s price by increasing the total number of shares available, which may influence the stock’s value and how the market perceives the company’s financial health.

non-derivative financial

"transaction_type": "non-derivative""

beneficially holds financial

"shares_following_transaction": "2078017.0000"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aveanna Healthcare (AVAH) disclose in this Form 4?

Aveanna Healthcare (AVAH) disclosed that director Rodney D. Windley sold 180,000 shares of common stock on August 20, 2026 at $11.50 per share, in a transaction reported as a sale of non-derivative securities.

How many Aveanna (AVAH) shares does Rodney D. Windley hold after this sale?

After the reported sale, Rodney D. Windley beneficially holds 2,078,017 shares of Aveanna Healthcare common stock in direct ownership, as stated in the Form 4 filing’s post-transaction holdings field.

What role did this Form 4 sale play in Aveanna (AVAH)’s secondary offering?

The footnote states the 180,000 shares sold by Rodney D. Windley were part of a secondary offering of 15,000,000 shares of Aveanna common stock, which closed on August 24, 2026.

At what price were the Aveanna (AVAH) shares sold in this insider transaction?

The shares were sold at a price of $11.50 per share. This price applies to the 180,000 shares of Aveanna common stock reported as sold by director Rodney D. Windley on August 20, 2026.

Is the Aveanna (AVAH) Form 4 transaction part of a derivative or option exercise?

No. The Form 4 classifies the transaction as involving non-derivative securities, specifically Aveanna common stock. There are no derivative transactions reported in this filing’s derivative summary.

Was the Aveanna (AVAH) insider sale reported under a Rule 10b5-1 trading plan?

The filing does not state that the 180,000‑share sale by Rodney D. Windley was made pursuant to a Rule 10b5-1 trading plan in the transaction footnote, and it is reported simply as a sale in connection with a secondary offering.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 04:30 PM EDT Accepted by SEC EDGAR 08/24/2026 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Windley Rodney D

(Last) (First) (Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA GEORGIA 30339

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	08/20/2026		S		180,000(1)	D	$11.5	2,078,017	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares sold by the reporting person were part of an undewritten secondary offering of 15,000,000 shares of the Issuer's common stock which closed on August 24, 2026.

	/s/ Jonathan Beckler, Attorney-in-Fact	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)